Comparison of cytotoxicity of vascular prostheses in vitro

Cover Page

Abstract


Aim. To study and compare cytotoxicity of the main types of synthetic prostheses used in arterial reconstructive surgery, including polytetrafluoroethylene (PTFE) and polyethylene-terephthalate (Dacron).

Materials and Methods. On the culture of human umbilical vein endothelial cells (HUVEC) of the 3rd passage, MTS test was conducted that is used in laboratory examinations with attraction of cellular technologies to study cytotoxicity of medical drugs and medical products. The test
implies use of MTS reagent that is 3-(4,5-dimethylthiazol-2-il)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium; additionally phenazine methosulfate (PMS) was used that plays the role of electron-binding reagent. In the experiment, cells were incubated with PTFE and Dacron within 24 hours at 37ᵒC with 5% CO2. For control, HUVEC cultured in the standard growth
medium, were used. In the presence of PMS, MTS was reduced by mitochondrial dehydrogenases of endothelial cells to formazan staining blue. Supernatant of cell cultures was evaluated by
photocolorimetric method on Stat Fax 3200 analyzer (microplate reader) of Awareness technology Inc. Palm City Fl. (USA).

Results. The lowest mean values were noted in Dacron group – 0.21 (0.20-0.22) optical density units, the highest values were noted in the control group – 0.36 (0.35-0.38); parameters in PTFE group were 0.35 (0.33-0.36). In comparison of the groups statistically significant differences were found between the control group and Dacron group (р<0.001), control and PTFE group (р=0.037), Dacron and PTFE (р<0.001). Incubation with Dacron led to suppression of metabolic activity of cells by 41.7% as compared to the control group (р<0.001). Metabolic activity of cells exposed to PTFE, approached that of the control group, that is, it corresponded to the optimal conditions of culturing of endothelial cells in vitro.

Conclusion. In comparison with polyethylene-terephthalate (Dacron), polytetrafluoro-ethylene (PTFE) showed the least suppression of metabolic activity of endothelial cells in vitro.


Full Text

The optimal method of revascularization in the open reconstructive surgery of peripheral arteries is use of autologous materials, in particular, of large saphenous vein. Rarely, in complicated surgical situations, freshly made or cryopreserved allogenous venous or arterial prostheses are used that may lead to immunosensitization reactions and uncontrolled degradation processes. In cases the autologous material is unavailable, vascular prostheses mostly of polytetrafluoroethylene (PTFE) and polyethylene-terephthalate (Dacron) are used.

Vascular conduits made of PTFE were first introduced into clinical practice in 1976 [1]. Prostheses made of Dacron have been used in cardiovascular surgery for more than 70 years. Nowadays, the most Dacron prostheses are coated with collagen or gelatin, or impregnated with silver; besides, to reduce thrombogenicity, they are coated with heparin [2].

In earlier studies, Dacron grafts showed satisfactory patency within 16 months with use of short sections 3.5 mm х 4 cm for coronary artery bypass [3]. Here, PTFE vascular prostheses used for coronary artery bypass showed only 14% patency within 45 months [4]. Nevertheless, small diameter synthetic grafts practically are not used at present because of high risks for development of complications.

With this, artificial prostheses find a wide use in reconstructive surgery of the aorta and major vessels. Some authors report safety and reliability profile of Dacron prostheses to be not lower than those of PTFE: according to the data of recent studies, structural defects occur not more than in 0.2% of cases in the long-term period after reconstruction [5]. However, in comparison with Dacron, PTFE is a less porous material due to which it is less permeable to blood; despite chemical inertness of the material, proteins and blood cells may deposit on PTFE as well [6]. According to some clinical studies, patency of PTFE and Dacron prostheses is comparable [7].

Early complications of reconstructive interventions may often be attributed to unsatisfactory biological compatibility of a prosthesis and a native vessel. Artificial grafts have a tendency to absence of endothelization in the areas outside the zones of anastomoses; finally, on parts of prosthesis deprived of endothelium, blood plasma protein, mainly fibrinogen and platelets, deposit forming the so called «pseudoneointima» reaching 1 mm thickness, which eventually predisposes the prosthesis to thrombosis and to increased risks of infection in bacteremia [8]. More severe late complications include hyperplasia of intima especially in the zone of distal anastomoses which develops by different mechanisms, cell interactions and physical factors associated with implantation of an artificial prosthesis [9]. Many experimental and clinical in vivo and in vitro studies were devoted to investigation of molecular-genetic aspects of patho-genesis and possible ways of prevention of development of peripheral atherosclerosis as such and of complications of reconstructive surgery including hyperplasia of intima, thrombosis, ischemia-reperfusion [10-13].

In physiological conditions, endothelium has athrombogenic surface on which chondroitin and heparin sulfates are expressed; anticoagulation properties of intima are also ensured by production of prostaglandin I2, nitric oxide (II) and ADP-ase [14]. Impossibility to fully reproduce athrombogenic properties of a native vessel in an artificial vascular prosthesis, on the whole predetermines the destiny of artificial materials in the arteries in surgery of peripheral arteries. An important role in development of complications is played by porosity of the material of vascular prostheses, compliance between an implanted graft and a native vessel, peculiarities of the blood flow in the zone of anastomosis.

Improvement of endothelization and hemocompatibility of vascular prostheses, as well as modification of their surface in general, serve to prevent deposition of different blood plasma proteins and to improve the long-term patency of artificial grafts. The inner lumen of grafts may be changed by application of different compounds, for example, hydrophilic polyethylene glycol, zwitterion polymers, heparin and others. However, excessive hydrophily prevents adhesion of endothelial cells and formation of the optimal inner lining of prostheses. Therefore, many research works are directed to improvement of the functional endothelization of prostheses by molecular- genetic methods [15,16].

In vitro study of the influence of artificial materials used in the vascular surgery, on cells of the vessel wall may provide additional insight into the mechanisms of interaction of cell elements of a native vessel, and also of blood and vascular prosthesis. Under study are peculiarities of adhesion of HUVEC to PTFE material, for example, after modification of the latter with low-temperature plasma; peculiarities of biocompatibility of different materials, for example, of silk fibroin and polyurethane membranes in culturing with HUVEC; cytotoxicity of artificial materials is evaluated in vitro for different kinds of exposure [17-19].

Evaluation of cytotoxicity in vitro in general is widely used in preclinical trials in studying the influence of different medical drugs and medical products on cell culture. Among the most requested in the routine laboratory practice are MTT and MTS tests.

MTT test is based on the ability of mitochondrial dehydrogenases of living and metabolically active cells to convert water-soluble 3-(4,5-dimethylthiazol-2-il)-2,5- diphenyl-2H-tetrazolium bromide (MTT) to formazan possessing a different extent of staining. In addition of dimethyl sulfoxide (DMSO) to formazan, the latter dissolves which permits to measure the optic density of the obtained solution, and, in this way, to evaluate metabolic activity of the studied cells and, accordingly, cytotoxicity of the studied substance or medical product.

A similar method of cytotoxicity uses MTS reagent 3-(4,5-dimethylthiazol-2-il)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl) -2H-tetrazolium in the presence of phenazine methosulfate (PMS) that plays the role of electron-binding reagent. MTS, like MTT, is reduced by cells to formazan; the extent of staining of the cellular supernatant may be measured by a photocolorimetric method (Figure 1) [20].

 

Fig. 1. The scheme of reduction of MTS to formazan under action of dehydrogenases

 

The most popular object for in vitro study of different vascular diseases and pathological conditions is human umbilical vein endothelial cells (HUVEC). HUVEC possess a number of advantages: convenient isolation, relatively low cost, easy culturing in laboratory conditions. HUVEC were first isolated and cultured in vitro by E. Jaffe, et al. in 1973 [21]. The HUVEC line is most commonly used in in vitro studies in the field of vascular biology. HUVEC are used both to study physiological processes occurring in the endothelium, and to model different pathological processes, in pharmacological research, and in studying effects of medical products.

In fundamental research human umbilical vein endothelial cells are often used as a model of choice for biomedical industry and preclinical experiments.

Thus, the aim of the given work was to study and compare cytotoxicity of the key types of synthetic prostheses used in the arterial reconstructive surgery including polytetrafluoroethylene (PTFE) and polyethylene-terephthalate (Dacron).

Materials and Methods

In the experiment, cultures of the primary endothelial cells of the human umbilical vein of 3rd passage were used. Isolation and culturing of cells were carried out in Laboratory of cell technologies of Central Scientific Research Laboratory of Ryazan State Medical University according to the standard accepted protocols. The tested objects were PTFE and polyethylene-terephthalate (Dacron) 4x4 mm in size of the same mass (25 mg). The design size and mass of the materials were selected taking into account the optimal coverage of the surface area of membrane inserts and the results of the pre-liminary experimental studies. As a control, growth endothelium medium ECGM (Cell Applications Sigma/Aldrich, catalogue number 211-500) was used that was added into a well on the plate in the quantity similar to that in other wells. The experiment was performed three times with different primary HUVEC lines to exclude measurement errors.

In the course of each experiment primary HUVEC were inoculated into the rows of wells of 12-well plate (Corning, catalogue number 3512) (3rd passage). The time of growth of cells in 12-cell plate before addition of the tested objects was 48 h at 37°С in a thermostat with 5% CO2 (CO2 incubator WS-180CS, World Science, Korea). On achievement of 80% confluence, the tested objects of 25 mg mass were introduced into the membrane inserts of 12-well plate (Corning, 6.5 mm, growth area 0.33 cm², pores 0.4 µm, catalogue number 3413) and were incubated for 24 hours at 37°С with 5% of CO2 (Table 1).

 

Table 1 Experimental Design

Time

Control

Dacron

PTFE

0 h

HUVEC 0.1 х 106

HUVEC 0.1 х 106

HUVEC 0.1 х 106

48 h

ECGM

25 mg of Dacron

25 mg of PTFE

72 h

MTS/PMS

MTS/PMS

MTS/PMS

73.5 h

Transfer of contents of wells to 96-well plate for measurement of optical density

 

After 24 hours, membrane inserts were taken out of the plates and were exposed to MTS/PMS reagents (Abcam, catalogue number ab223881) for 1.5 hour at 37°С with 5% CO2. After this period the obtained solutions (cell supernatant) with different extent of staining were transferred to 96-well plates (Corning, catalogue number 3599) for evaluation of the optical density on analyzer ((Stat Fax 3200 (microplate reader), Awareness technology Inc. Palm City Fl., USA)) at 490 nm (reference value 640 nm). From each well not less than 5 samples were taken to exclude measurement errors (Figure 2).

 

Fig. 2. 96-well plate with cell supernatant after incubation with MTS/PMS before measurement of optical density

 

Statistical processing of the data obtainned was carried out using software package Statistica 10.0 (Stat Soft Inc., USA).

Results and Discussion

The lowest average values of optical density in the supernatant were noted in Dacron group – 0.21 (0.2-0.22) optical density units (ODU), the highest values were noted in the control group 0.36 (0.35-0.38) ODU; parameters in PTFE group were 0.35 (0.33-0.36) ODU. Comparison of the studied groups showed statistically significant differences between the control and Dacron groups (р<0.001), control and PTFE (р=0.037), Dacron and PTFE (р<0.001, Figure 3).

 

Fig. 3. Comparison of the optical density values in the studied groups in the experiment on cytotoxicity

Note: all comparisons between groups are statistically significant (р<0.05)

 

Analysis of cytotoxicity implies investigation of the probability for the influence of some material on viability of cells, for example, on metabolic activity, integrity of cell membranes, cell growth. Study of cytotoxicity and/or viability of cells in vitro has a number of advantages, such as rapid implementation of examinations, relatively low cost and also a possibility of using human cells with no risk for patient’s health; besides, in vitro use of human cell lines may give more precise results than some in vivo experiments on animals.

There exists a large amount of methods for evaluation of cytotoxicity: 1) method excluding use of any dyes/kinds of staining; 2) colorimetric methods; 3) fluorometric methods; 4) luminometric methods. MTS-test used in the present work, along with MTT, XTT, WST-1, WST-8, LDH, SRB and NRU methods, is referred to colorimetric methods [22].

MTS-test is a rapid, sensitive and specific method to study cytotoxicity in vitro. A limitation of the method may be influence of time of incubation and type of cells on the results. However, the results of studies show that the choice of the optimal time of exposure to MTS gives reliable experimental results [22].

MTS-test may be used to study cyto- toxicity of materials applied in different fields of medicine both for evaluation of the direct contact with cells and also of indirect contact, for example, with use of membrane systems [23]. A study of cytotoxicity plays an important role in the cardiovascular surgery as well. Thus, works are under way to study prosthetic valves on the basis of LLDPE, PTFE, Dacron, bovine and porcine pericardium coated with hyaluronic acid, where methods of evaluation of cytotoxicity (LDN-methods) were actively used [24].

The experiment conducted by the authors showed that the most cytotoxic substance in relation to HUVEC was Dacron: examination of the optical density of supernatant obtained from cells incubated with this material demonstrated minimal parameters indicating 41.7% suppression of the metabolic activity of cells in comparison with the control group. Metabolic activity of cells exposed to PTFE was close to that of the control group (reduction of the optical density not more than by 2.8%), that is, it corresponded to the optimal conditions of functioning of endothelial cells in vitro.

Evaluation of cytotoxicity permits to study the reaction of cells to exposure to different materials. The work for studying cytotoxicity of the key materials used in vascular surgery, with application of MTS-test on the primary human umbilical vein endothelial cells being a convenient and available material for in vitro studies, showed a possible relatively simple and available laboratory method of evaluation of the influence of artificial prostheses on the main elements of the vascular wall. The method is reproducible, which was evidenced by the results of repeated experiments.

The approach used in the given work, provides a routine method to study the influence of different conditions of the extracellular environment, prosthetic coatings, chemical agents on metabolic activity of cells that may expand knowledge of the processes of hemocompatibility, endothelization of vascular prostheses and hyperplasia of intima in in vitro conditions.

Conclusions

  1. Polyethylene-terephthalate (Dacron) possesses a cytotoxic effect for the primary human umbilical vein endothelial cells in vitro, significantly suppressing metabolic activity of cells.
  2. In comparison with polyethylene terephthalate (Dacron), polytetrafluoroethylene produces a minimal damaging effect on endotheliocytes in vitro.
  3. MTS-test may be used for routine laboratory study of the influence of materials applied in reconstructive arterial interventions, on the cells of vascular system in vitro.

About the authors

Roman E. Kalinin

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0002-0817-9573
SPIN-code: 5009-2318
ResearcherId: M-1554-2016

Russian Federation, Ryazan

MD, professor, head. Department of Cardiovascular, Endovascular, Surgical Surgery and Topographic Anatomy

Igor A. Suchkov

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0002-1292-5452
SPIN-code: 6473-8662
Scopus Author ID: M-1180-2016

Russian Federation, Ryazan

MD, PhD, Professor, Professor of the Department of Cardiovascular, Endovascular, Operative Surgery and Topographic Anatomy

Nina D. Mzhavanadze

Ryazan State Medical University

Author for correspondence.
Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0001-5437-1112
SPIN-code: 7757-8854
ResearcherId: M-1732-2016

Russian Federation, Ryazan

MD, PhD, Associate Professor of the Department of Cardiovascular, Endovascular, Operative Surgery and Topographic Anatomy; Senior Researcher at the Central Research Laboratory

Natalya V. Korotkova

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0001-7974-2450
SPIN-code: 3651-3813
ResearcherId: I-8028-2018

Russian Federation, Ryazan

MD, PhD, Associate Professor of the Department of Biochemical Chemistry with Clinical Laboratory Diagnostics Course of the Faculty of Additional Professional Education; Senior Researcher at the Central Research Laboratory

Aleksandr A. Nikiforov

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0002-7364-7687
SPIN-code: 8713-0596

Russian Federation, Ryazan

MD, PhD, Associate Professor, Head of the Central Research Laboratory

 

Ivan Yu. Surov

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0002-0794-4544
SPIN-code: 1489-7481

Russian Federation, Ryazan

Student of the General Medicine Faculty

Polina Yu. Ivanova

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0001-6943-0277

Russian Federation, Ryazan

Student of the General Medicine Faculty

Anastasiya D. Bozhenova

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0002-2790-0303

Russian Federation, Ryazan

Student of the General Medicine Faculty

Ekaterina A. Strelnikova

Ryazan State Medical University

Email: nina_mzhavanadze@mail.ru
ORCID iD: 0000-0002-3370-1095

Russian Federation, Ryazan

Student of the Preventive Health Faculty

References

  1. Campbell CD, Brooks DH, Webster MW, et al. The use of expanded microporous polytetrafluoroethylene for limb salvage: a preliminary report. Surgery. 1976;79(5):485-91.
  2. Eiberg JP, Røder O, Stahl-Madsen M, et al. Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial. European Journal of Vascular and Endovascular Surgery. 2006;32(4):431-8. doi:10.1016/j. ejvs.2006.04.018
  3. Sauvage LR, Schloemer R, Wood SJ, et al. Successful Interposition Synthetic Graft Between Aorta and Right Coronary Artery. Angiographic Follow-Up to Sixteen Months. The Journal of Thoracic and Cardiovascular Surgery. 1976;72(3):418‐21.
  4. Chard RB, Johnson DC, Nunn GR, et al. Aorta- Coronary Bypass Grafting with Polytetrafluoroethylene Conduits. Early and Late Outcome in Eight Patients. The Journal of Thoracic and Cardiovascular Surgery. 1987;94(1):132-4.
  5. Van Damme H, Deprez M, Creemers E, et al. Intrinsic Structural Failure of Polyester (Dacron) Vascular Grafts. A General Review. Acta Chirurgica Belgica. 2005; 105(3):249-55. doi: 10.1080/00015458.2005.11679712
  6. Greisler HP, editor. New Biologic and Synthetic Vascular Prostheses. Austin: R.G. Landes Co; 1991.
  7. Abbott WM, Green RM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. Journal of Vascular Surgery. 1997;25(1):19-28. doi:10.1016/ S0741-5214(97)70317-3
  8. Padera RF, Schoen FJ. Cardiovascular medical devices. In: Ratner B.D., Hoffman A.S., Schoen F.J., et al., editors. Biomaterials Science: an introduction to materials in medicine. 2nd ed. San Diego: Elsiver Academic Press; 2004. Pt. II, chr. 7.3. P. 470-93.
  9. Byrom MJ, Ng MK, Bannon PG. Biomechanics and biocompatibility of the perfect conduit-can we build one? Annals of Cardiothoracic Surgery. 2013;2(4): 435-43. doi: 10.3978/j.issn.2225-319X.2013.05.04
  10. Kalinin RE, Suchkov IA, Korotkova NV, et al. The research of the molecular mechanisms of endothelial dysfunction in vitro. Genes & Cells. 2019;14(1):22-32. (In Russ). doi: 10.23868/201903003
  11. Kalinin RE, Abalenikhina YuV, Pshennikov AS, et al. Interrelation between oxidative carbonylation of proteins and lysosomal proteolysis of plasma in experimentally modelled ischemia and ischemia-reperfusion. Nauka Molodykh (Eruditio Juvenium). 2017;5(3): 338-51. (In Russ). doi: 10.23888/HMJ20173338-351
  12. Suchkov IA, Pshennikov AS, Gerasimov АА, et al. Prophylaxis of restenosis in reconstructive surgery of main arteries. Nauka Molodykh (Eruditio Juvenium). 2013;(2):12-9. (In Russ).
  13. Kalinin RE, Suchkov IA, Klimentova EA, et al. Apoptosis in vascular pathology: present and future. I.P. Pavlov Russian Medical Biological Herald. 2020;28(1):79-87. (In Russ). doi: 10.23888/PAVLOVJ202028179-87
  14. Marcus AJ, Broekman MJ, Drosopoulos JH, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. The Journal of Clinical Investigation. 1997;99(6):1351‐60. doi:10. 1172/JCI119294
  15. Ren X, Feng Y, Guo J, et al. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. Chemical Society Reviews. 2015;44(15):5680-742. doi: 10.1039/c4cs00483c
  16. Adipurnama I, Yang MC, Ciach T, et al. Surface modification and endothelialization of polyurethane for vascular tissue engineering applications: a review. Biomaterials Science. 2016;5(1):22-37. doi: 10.1039/c6bm00618c
  17. Vig K, Swain K, Mlambo T, et al. Adhesion of human umbilical vein endothelial cells (HUVEC) on PTFE material following surface modification by low temperature plasma treatment. Physiology. 2019;33(1):603.3.
  18. Zhou M, Wang WC, Liao YG, et al. In vitro biocompatibility evaluation of silk-fibroin/polyurethane membrane with cultivation of HUVECs. Frontiers of Materials Science. 2014;8:63-71. doi:10.1007/ s11706-014-0230-3
  19. Shtanskiy DV, Glushankova NA, Kiryukhantsev-Korneyev FV, et al. Sravnitel’noye issledovaniye struktury i tsitotoksichnosti politetraftor•etilena posle ionnogo travleniya i ionnoy implantatsii. Fizika Tverdogo Tela. 2011;53(3):593-7. (In Russ).
  20. Baydamshina DR, Trizna EY, Holyavka MG, et al. Assessment of genotoxicity and cytotoxicity for preparations of the trypsin immobilized on chitozan matrix. Proceedings of Voronezh State University. Series: Chemistry, Biology, Pharmacy. 2016;(3):53-7. (In Russ).
  21. Jaffe EA, Nachman RL, Becker CG, et al. Culture of Human Endothelial Cells Derived from Umbilical Veins. Identification by Morphologic and Immunologic Criteria. The Journal of Clinical Investigation. 1973;52(11): 2745-56. doi: 10.1172/JCI107470
  22. Aslantürk ÖS. In Vitro Cytotoxicity and Cell Viability Assays: Principles, Advantages, and Disadvantages. In: Genotoxicity – A Predictable Risk to Our Actual World. 2018. Available at: https://cdn. intechopen.com/pdfs/57717.pdf. Accessed: 2020 May 21. doi: 10.5772/intechopen.71923
  23. Albulescu R, Popa A-C, Enciu A-M, et al. Comprehensive In Vitro Testing of Calcium Phosphate-Based Bioceramics with Orthopedic and Dentistry Applications. Materials. 2019;12(22):3704. doi:10. 3390/ma12223704
  24. Emch О, Cavicchia J, Dasi P, et al. Hemocompatibility of Various Heart Valve Materials. In: Society for Biomaterials. Annual Meeting and Exposition. Pioneering the Future of Biomaterials. Transactions of the 38th Annual Meeting. 2014. Vol. XXXVI. Art. 28. Available at: http://abstracts.biomaterials.org/data/papers/ 2014/0332-000967.pdf. Accessed: 2020 May 21.

Supplementary files

Supplementary Files Action
1.
Fig. 1. The scheme of reduction of MTS to formazan under action of dehydrogenases

Download (29KB) Indexing metadata
2.
Fig. 2. 96-well plate with cell supernatant after incubation with MTS/PMS before measurement of optical density

Download (101KB) Indexing metadata
3.
Fig. 3. Comparison of the optical density values in the studied groups in the experiment on cytotoxicity

Download (26KB) Indexing metadata

Statistics

Views

Abstract - 153

PDF (Russian) - 22

PDF (English) - 13

PDF (简体中文) - 7

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2020 Kalinin R.E., Suchkov I.A., Mzhavanadze N.D., Korotkova N.V., Nikiforov A.A., Surov I.Y., Ivanova P.Y., Bozhenova A.D., Strelnikova E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies